Hepion Pharmaceuticals (HEPA) awards director 299K stock options
Rhea-AI Filing Summary
Hepion Pharmaceuticals, Inc. (HEPA) reported that director James Gordon Liddy received a grant of stock options. The award covers 299,000 stock options, each for one share of common stock, with an exercise price of $0.08 per share, exercisable from August 19, 2027 until August 19, 2036. Following this grant, he holds 299,000 stock options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Liddy James Gordon
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 299,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options — 299,000 shares (Direct)
Key Figures
Stock options granted: 299,000 options
Exercise price: $0.08 per share
Underlying common stock: 299,000 shares
+3 more
6 metrics
Stock options granted
299,000 options
Grant of stock options to director James Gordon Liddy
Exercise price
$0.08 per share
Exercise price of the granted stock options
Underlying common stock
299,000 shares
Shares of common stock underlying the options
Exercise date
August 19, 2027
Date from which the options are exercisable
Expiration date
August 19, 2036
Expiration of the granted stock options
Options held after transaction
299,000 options
Total stock options directly held by James Gordon Liddy after the grant
Key Terms
Stock Options, exercise price, expiration date
3 terms
Stock Options financial
"The award covers 299,000 <b>stock options</b>, each for one share"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"with an <b>exercise price</b> of $0.08 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"and an <b>expiration date</b> of August 19, 2036"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did HEPA disclose for James Gordon Liddy?
HEPA disclosed that director James Gordon Liddy received a grant of 299,000 stock options for common stock at an exercise price of $0.08 per share, exercisable from August 19, 2027 to August 19, 2036. After the grant, he directly holds 299,000 options.
Was the HEPA Form 4 transaction a buy or a sell?
The Form 4 for HEPA reports an acquisition of derivative securities. James Gordon Liddy received a grant of 299,000 stock options; there were no reported sales of common stock or options in this filing.
What is the exercise price of the options granted in the HEPA Form 4?
The stock options granted to James Gordon Liddy have an exercise price of $0.08 per share for the underlying HEPA common stock, as reported in the Form 4 transaction details.
When do the HEPA options granted to James Gordon Liddy become exercisable and when do they expire?
The reported stock options associated with HEPA become exercisable on August 19, 2027 and have an expiration date of August 19, 2036, providing a multi-year window in which they may be exercised.
How many HEPA stock options does James Gordon Liddy hold after this transaction?
After this grant, James Gordon Liddy is reported to hold 299,000 stock options directly, each representing the right to acquire one share of HEPA common stock, according to the Form 4 data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
